Neurorehabilitation and Pain Management [email protected] | +90 0542 215 80 80

Botulinum Toxin A in Stroke Treatment

Botulinum toxin is a preferred treatment method in stroke patients. The muscles, which contract involuntarily in stroke patients with brain injury, can be relaxed with botulinum toxin A injections.

In the late phase of the disease, the muscles of hand, arm, and legs may involuntarily contract in stroke patients. These contractions are called spasticity. Spasticity may impair the hand and gait functions.


In stroke treatment, botulinum toxin A injection enables the relaxation of the contracted muscles, which interrupt the normal functioning of the organs.
With the botulinum toxin A administration, which is an adjuvant intervention in the stroke treatment, an improvement in the hand, arm and leg movements can be achieved. Botulinum toxin A, which relaxes the contracted muscles, contributes to the improvement in stroke patients together with the robotic physiotherapy used for the hemiplegia rehabilitation.


Botulinum toxin injection can be administered with different methods. The contracted muscle is determined with physical examination and the drug is injected directly into the muscle. For a satisfying result, the injection should be done into the correct region of the muscle. The efficacy of the botulinum toxin A injections can be increased with the guidance of EMG or US.


The effect of the botulinum toxin A lasts approx. 4-6 months. If the effect of the botulinum toxin A is combined with an intensive and comprehensive rehabilitation period, persistent recovery in the functions can be achieved. In cases, in whom botulinum toxin A injections provided good results, it may be repeated in approx. 6-month intervals.